AMPH Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable & inhalation products. Its products are used in hospitals or urgent care clinical settings.

$17.87  +0.09 (0.51%)
As of 04/09/2021 15:59:42 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  06/25/2014
Outstanding shares:  47,432,937
Average volume:  170,545
Market cap:   $848,575,243
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    03209R103
ISIN:        US03209R1032
Sedol:      BNFWZS4
Valuation   (See tab for details)
PE ratio:   604.84
PB ratio:   2.11
PS ratio:   2.43
Return on equity:   0.35%
Net income %:   0.40%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy